Traders pound USANA's stock over slowdown in China sales
USANA Health Sciences reported $232.6 million in net sales in its fourth quarter, a 2.1% year-over-year increase. That amounted to $1.83 in earnings per share, but these figures disappointed analysts, and the company’s share price tumbled as a result.